Daniel Valia

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

Mehreen S. Datoo, Hamtandi Magloire Natama, Ousmane Traoré et al. · The Lancet · 2021 · 431 citations · Full text

Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial

Mehreen S. Datoo, Hamtandi Magloire Natama, Duncan Bellamy et al. · The Lancet Infectious Diseases · 2022 · 268 citations

Vaccination, Clinical Malaria, Burkina Faso +8

Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial

Halidou Tinto, Walter Otieno, Samwel Gesase et al. · The Lancet Infectious Diseases · 2019 · 68 citations

Vaccination, Vaccine Safety, Pediatric Epidemiology +10

Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso

Daniel Valia, Brecht Ingelbeen, Bérenger Kaboré et al. · Antimicrobial Resistance and Infection Control · 2022 · 39 citations · Full text

Gender differences in sociodemographic and behavioural factors associated with BMI in an adult population in rural Burkina Faso – an AWI-Gen sub-study

Palwendé Romuald Boua, Hermann Sorgho, Toussaint Rouamba et al. · Global Health Action · 2018 · 16 citations · Full text